Septicaemia in acute leukaemia.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000380:Agranulocytosis / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000150:complications; D006801:Humans; D007275:Injections, Intravenous; D007938:Leukemia / Q000150:complications*; D007945:Leukemia, Lymphoid / Q000453:epidemiology; D007951:Leukemia, Myeloid / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology; D009181:Mycoses / Q000150:complications; D009365:Neoplasm Regression, Spontaneous; D011512:Proteus Infections / Q000150:complications; D011552:Pseudomonas Infections / Q000150:complications; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D013203:Staphylococcal Infections / Q000150:complications; D013290:Streptococcal Infections / Q000150:complications; D013297:Streptococcus pyogenes
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents